NCT02475213 · Interventional trial
Safety Study of Enoblituzumab (MGA271) in Combination With Pembrolizumab or MGA012 in Refractory Cancer
Overall registry status Completed
Phase 1
Conditions Head and Neck Cancer, Melanoma, Non Small Cell Lung Cancer, Urothelial Carcinoma
Delaware Valley sites
- Hospital of the University of Pennsylvania/Abramson Cancer Center · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory